Abstract
Abstract
Monitoring morbidity and mortality in resurgences of respiratory infections poses significant challenges, as shown by coronavirus disease 2019 (COVID-19). For example, case fatality rates and deaths attributed to specific respiratory pathogens are known to suffer from significant biases undermining their comparability through time and space. As a result, it is difficult to evaluate the protective effect of public health interventions or quantify the impact of a resurgence on the general population through direct recording of COVID-19 related deaths. To overcome these limitations, more robust, less-biased metrics, such as all-cause deaths, have been proposed for monitoring the effect of an epidemic over a population and over time. More specifically, metrics of excess mortality over time, which have been used for influenza surveillance in the past, are increasingly considered important for COVID-19 surveillance. Here, we discuss excess mortality surveillance focusing on standardized single-point and standardized cumulative metrics that allow comparability of excess mortality through space and time. We explain why z score allows for comparison of excess mortality between countries and different periods, while cumulative z score allows assessment of excess mortality over long periods. Our commentary reiterates the importance of standardized statistics of excess mortality for COVID-19 surveillance as we move toward a coexistence with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that will allow drawing conclusions from best practices in different health systems and different periods.
Publisher
Oxford University Press (OUP)
Reference18 articles.
1. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21;Wang;Lancet (North American ed),2022
2. Data resource profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths;Riffe;Int J Epidemiol,2021
3. Case fatality ratio of pandemic influenza;Nishiura;Infect Dis,2010
4. Global excess deaths associated with COVID-19;World Health Organization
5. Quantifying and communicating the burden of COVID-19;Cube;BMC Med Res Methodol,2021